| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000048582 |
| Receipt No. | R000055194 |
| Scientific Title | Effect of standardized blood collection procedures from closed-needleless hub of vascular catheters by a blood collection specialist on blood-culture contamination rates, a retrospective cohort study |
| Date of disclosure of the study information | 2022/08/07 |
| Last modified on | 2022/08/04 (Ver. 1) |
| Basic information | ||
| Public title | Effect of standardized blood collection procedures from closed-needleless hub of vascular catheters by a blood collection specialist on blood-culture contamination rates, a retrospective cohort study | |
| Acronym | Effect of standardized blood collection procedures from closed-needleless hub of vascular catheters by a blood collection specialist on blood-culture contamination rates, a retrospective cohort study | |
| Scientific Title | Effect of standardized blood collection procedures from closed-needleless hub of vascular catheters by a blood collection specialist on blood-culture contamination rates, a retrospective cohort study | |
| Scientific Title:Acronym | Effect of standardized blood collection procedures from closed-needleless hub of vascular catheters by a blood collection specialist on blood-culture contamination rates, a retrospective cohort study | |
| Region |
|
|
| Condition | |||
| Condition | sepsis | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | Several studies have been conducted on contamination rates, among which blood sampling from vascular catheters is known to increase the contamination rate. Therefore, blood sampling from peripheral veins is recommended in much of the literature, except in cases of suspected catheter-related bloodstream infection or when blood sampling from a peripheral vein is not feasible.
However, many previous reports of increased contamination rates with blood collection from vascular catheters have acknowledged multiple problems, including open blood collection, inconsistent blood collection techniques and blood collection by healthcare professionals not trained in blood collection from catheters. Recently, it has been reported that closed blood collection and blood collection by medical personnel trained in blood collection can reduce contamination rates, and the contamination rate of blood collection from vascular catheters may be lower than in the past, depending on the shape of the blood collection site of the device, the blood collection procedure and the medical personnel collecting blood. However, as far as we could find, there are no studies in which blood culture tests were drawn closed via vascular catheters using a strictly standardized procedure, and at present the contamination rate when blood is drawn closed via vascular catheters using a standardized procedure is unknown. Blood collection from vascular catheters is generally easier and less painful, and if there is no difference in contamination rates compared with conventional methods, this would be of benefit to both healthcare staffs and patients. In the present study, we investigated retrospectively whether the contamination rate of blood culture test using blood collected from closed-needleless hubs of vascular catheters by a skilled medical staff using standardized procedure differs from the contamination rate when blood is collected in a conventional manner. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Contamination rates for blood culture tests |
| Key secondary outcomes | Positive rate of blood culture tests |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients for whom blood culture tests have been performed | |||
| Key exclusion criteria | none | |||
| Target sample size | 4000 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Hyogo Prefectural Amagasaki General Medical Center | ||||||
| Division name | Department of Emergency and Critical Care Medicine | ||||||
| Zip code | 660-8550 | ||||||
| Address | 2-17-77 Higashinaniwa-cho, Amagasaki, Hyogo, Japan | ||||||
| TEL | 06-6480-7000 | ||||||
| tsunemitsu0730@yahoo.co.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Hyogo Prefectural Amagasaki General Medical Center | ||||||
| Division name | Department of Emergency and Critical Care Medicine | ||||||
| Zip code | 660 | ||||||
| Address | 2-17-77 Higashinaniwa-cho, Amagasaki, Hyogo, Japan | ||||||
| TEL | 06-6480-7000 | ||||||
| Homepage URL | |||||||
| tsunemitsu0730@yahoo.co.jp | |||||||
| Sponsor | |
| Institute | Department of Emergency and Critical Care Medicine, Hyogo Prefectural Amagasaki General Medical Center, Hyogo, Japan |
| Institute | |
| Department | |
| Funding Source | |
| Organization | none |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Hyogo Prefectural Amagasaki General Medical Center Research Ethics Committee / Institutional Review Board |
| Address | 2-17-77 Higashinaniwa-cho, Amagasaki, Hyogo, Japan |
| Tel | 0664807000 |
| agmc.irb@gmail.com | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 4500 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | none |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000055194 |